Lexicon Pharmaceuticals
LXRX
LXRX
121 hedge funds and large institutions have $344M invested in Lexicon Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.38% less ownership
Funds ownership: 70.59% → 70.21% (-0.38%)
2% less funds holding
Funds holding: 123 → 121 (-2)
37% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 41
Holders
121
Holding in Top 10
1
Calls
$3.78M
Puts
$450K
Top Buyers
| 1 | +$3.56M | |
| 2 | +$2.95M | |
| 3 | +$935K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$906K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$732K |
Top Sellers
| 1 | -$5.06M | |
| 2 | -$2.2M | |
| 3 | -$1.48M | |
| 4 |
HF
HRT Financial
New York
|
-$590K |
| 5 |
Jane Street
New York
|
-$470K |
